EP 4247437 A1 20230927 - RADIOLABELLED COMPOUNDS FOR DIAGNOSING CHOLINERGIC NEURODEGENERATIVE DISEASES
Title (en)
RADIOLABELLED COMPOUNDS FOR DIAGNOSING CHOLINERGIC NEURODEGENERATIVE DISEASES
Title (de)
RADIOAKTIV MARKIERTE VERBINDUNGEN ZUR DIAGNOSE VON CHOLINERGEN NEURODEGENERATIVEN ERKRANKUNGEN
Title (fr)
COMPOSÉS RADIOMARQUÉS POUR LE DIAGNOSTIC DE MALADIES NEURODÉGÉNÉRATIVES CHOLINERGIQUES
Publication
Application
Priority
- FR 2012024 A 20201123
- EP 2021082619 W 20211123
Abstract (en)
[origin: CA3198747A1] The present invention relates to the radiolabelled compound of enantiomer (R, R) of 5-fluoro-3-4(-phenylpiperidin-1-yl)-1,2,3,4-tetrahydronaphthalen-2-ol, as well as said compound for use in a method for in-vivo diagnosis of, in particular, a cholinergic neurodegenerative disease, for example chosen from the group consisting of Alzheimer's disease, dysmnesia, learning disabilities, schizophrenia, cognitive dysfunction, hyperactivity disorder, anxiety neurosis, depression, analgesia and Parkinson's disease.
IPC 8 full level
A61K 51/04 (2006.01); C07B 59/00 (2006.01); C07D 211/14 (2006.01); C07F 5/02 (2006.01); C07F 17/00 (2006.01); A61K 101/02 (2006.01)
CPC (source: EP US)
A61K 51/0455 (2013.01 - EP US); C07B 59/002 (2013.01 - EP); C07D 211/14 (2013.01 - EP US); C07F 5/025 (2013.01 - EP US); C07F 17/00 (2013.01 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
FR 3116433 A1 20220527; FR 3116433 B1 20231215; CA 3198747 A1 20220527; EP 4247437 A1 20230927; US 2024058481 A1 20240222; WO 2022106714 A1 20220527
DOCDB simple family (application)
FR 2012024 A 20201123; CA 3198747 A 20211123; EP 2021082619 W 20211123; EP 21811091 A 20211123; US 202118253953 A 20211123